{"answers":{"affected":"","exploited":"There is no known exploitation of CVE-2026-52866 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2026-52866 yet. Limit exposure of the affected software until one is available.","what":"CVE-2026-52866 is a high-severity missing authorization vulnerability in Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT), published on 18 Jun 2026. It can only be exploited from the same machine or local network, with no action from the victim."},"fix_prompt":"Check this codebase for CVE-2026-52866 and fix it if it is affected.\n\nWhat it is: CVE-2026-52866 is a high-severity missing authorization vulnerability in Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT), published on 18 Jun 2026. It can only be exploited from the same machine or local network, with no action from the victim.\nExploitation: There is no known exploitation of CVE-2026-52866 in the wild and no public exploit code.\n\nAffected product: Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT). No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2026-52866/ (Markdown: https://insights.sbomify.com/CVE-2026-52866/index.md)","id":"CVE-2026-52866","markdown":"https://insights.sbomify.com/CVE-2026-52866/index.md","name":"CVE-2026-52866","record":{"aliases":["GHSA-47r7-422p-6w2p"],"analysis":{"component_type":"iot_embedded","fix_type":"no_fix_stated","impacts":["denial_of_service"],"network_reachable":"adjacent_or_local","non_default_config":false,"product_category":"Blood Glucose Monitor","requires_auth":"none","summary":"An attacker within Bluetooth range can monopolize the connection slot, preventing legitimate users from connecting to the blood glucose monitor.","user_interaction":"not_required","vuln_class":"missing_authorization"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"icscert","cpe":[],"cvss":{"score":7.1,"severity":"high","source":"cna","vector":"CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N","version":"4.0"},"cwes":[{"id":"CWE-862","name":"Missing Authorization"}],"description":"An attacker within BLE communication range can monopolize the device's \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization","id":"CVE-2026-52866","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"missing_authorization","year":"2026"},"n_packages":0,"n_references":4,"next":{"headline":"OFFIS DCMTK Toolkit Path Traversal","id":"CVE-2026-52868"},"packages":[],"prev":{"headline":"NGINX Ingress Controller vulnerability","id":"CVE-2026-52865"},"products":["Blood Glucose Monitoring System (Model No. APG-01 BT)"],"published":"2026-06-18","related":[],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"no","exploitation":"none","technical_impact":"partial"},"state":"PUBLISHED","updated":"2026-06-22","vendors":["Apollo Pharmacy"]},"summary":"An attacker within Bluetooth range can monopolize the connection slot, preventing legitimate users from connecting to the blood glucose monitor.","url":"https://insights.sbomify.com/CVE-2026-52866/"}